English | Español
Jamie Barrand | Dec 12, 2015

BioBlast researchers develop new therapies for oculopharyngeal muscular dystrophy

Jamie Barrand | Dec 12, 2015

Astellas researchers release results of Cresemba study
Jamie Barrand | Dec 12, 2015

FDA grant to fund NORD rare disease studies
Jamie Barrand | Dec 11, 2015

Baxalta receives FDA approval for von Willebrand disease treatment
Jamie Barrand | Dec 11, 2015

Merck presents Keytruda study results at American Society of Hematology meeting

Jamie Barrand | Dec 10, 2015

Two Biogen therapies prove effective for treating hemophilia
Jamie Barrand | Dec 10, 2015

Association of Black Cardiologists, PhRMA detail new treatments for heart disease, stroke patients
Jamie Barrand | Dec 10, 2015

Boehringer Ingelheim researchers test nintedanib on patients with severe lung disease

Trending
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
+ Regulatory
Patient Daily | Nov 6, 2025

Executive Director of Patients Come First on lawsuit ads: ‘One of the most pervasive and least regulated forces in consumer media’
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’